AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

1.500

+0.0856.01%

Volume:480.03K

Turnover:707.04K

Market Cap:405.51M

PE:-7.16

High:1.515

Open:1.415

Low:1.415

Close:1.415

Loading ...

Overview Company News Filings

Imricor Medical Systems Files Second Premarket Approval Module With US FDA; Shares Down 3%

MT Newswires Live

Imricor Medical Systems Reports Full Year 2024 Earnings

Simply Wall St.

When Will Imricor Medical Systems, Inc. (ASX:IMR) Breakeven?

Simply Wall St.

Corrected-Imricor Medical Systems Inc - Net Loss for Year $29.7 Mln (Corrects Currency to USD)

THOMSON REUTERS

BUZZ-Australia's Imricor Medical Systems rises after annual loss narrows

BRIEF-Imricor Medical Systems Says Net Loss For Year A$29.7 Million

Imricor Medical Systems - FY Adjusted Net Loss a$15.6 Mln

THOMSON REUTERS

Imricor Medical Systems' Catheter Receives CE Mark Certification

MT Newswires Live

Imricor Medical Systems' Consumables Revenue Soars in Q4 2024; Shares Up 3%

MT Newswires Live

5E Advanced Materials grabs first Runners gong for new year

The West Australian

Why Brainchip, Imricor, Strike Energy, and Wildcat shares are rising today

BRIEF-Imricor Medical Systems Received First Purchase Order From Qatar

Imricor Medical Systems Secures First Order for Imaging System in Middle East; Shares Climb 9%

MT Newswires Live

BUZZ-Australia's Imricor Medical Systems jumps on purchase order

Imricor Medical Systems Inc - Received Its First Purchase Order for Capital Equipment and Consumables From Qatar

THOMSON REUTERS

Imricor Medical Systems Submits 3D Mapping System for CE Mark Approval in Europe; Shares Up 7%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMR.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.5,"timestamp":1741151520000,"preClose":1.415,"halted":0,"volume":480033,"delay":0,"changeRate":0.060071,"change":0.085,"floatShares":222684651,"shares":270339701,"eps":-0.20937172,"lyrEps":-0.209372,"pbRate":-34.8,"amount":707039,"amplitude":0.070671,"volumeRatio":1.5486254309273757,"dividePrice":0,"prevYearClose":1.36,"fiveDayClose":1.46,"twentyDayClose":1.28},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":222684651,"roa":"-68.06%","roe":"-274.56%","lyrEps":-0.209372,"volumeRatio":1.5486254309273757,"shares":270339701,"dividePrice":0,"high":1.515,"amplitude":0.070671,"preClose":1.415,"low":1.415,"week52Low":0.41,"pbRate":"-34.80","psRate":"267.59","week52High":1.7,"institutionHeld":0,"latestPrice":1.5,"eps":-0.20937171269810687,"divideRate":0,"volume":480033,"delay":0,"ttmEps":-0.20937171269810687,"open":1.415,"prevYearClose":1.36,"prevWeekClose":1.58,"prevMonthClose":1.58,"prevQuarterClose":1.36,"fiveDayClose":1.46,"twentyDayClose":1.28,"sixtyDayClose":1.235},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null},{"date":"2024-04-30","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714435200000,"name":null,"time":"","dateTimestamp":1714399200000,"actualEps":null},{"date":"2024-02-29","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709161200000,"name":null,"time":"","dateTimestamp":1709125200000,"actualEps":null},{"market":"AU","date":"2024-02-05","symbol":"IMR.AU","defaultRemindTime":1707087600000,"type":"split","dateTimestamp":1707051600000,"forFactor":968436,"toFactor":1000000,"ratio":0.968436}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516553693","title":"Imricor Medical Systems Files Second Premarket Approval Module With US FDA; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516553693","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516553693?lang=en_us&edition=fundamental","pubTime":"2025-03-04 08:24","pubTimestamp":1741047884,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  submitted its second premarket approval module for US Food and Drug Administration  review, according to a Tuesday filing with the Australian bourse.The module covers design, manufacturing, and quality processes for seven products, and includes design controls, raw material receipt, inspection, storage, build procedures, process validation, part and device traceability, and quality management systems, the filing said.The company's NorthStar 3D mapping and guidance system will be submitted next under the 510 process.Shares fell nearly 3% in morning trade Tuesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7007","IMR.AU","BK7503"],"gpt_icon":0},{"id":"2516621315","title":"Imricor Medical Systems Reports Full Year 2024 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2516621315","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516621315?lang=en_us&edition=fundamental","pubTime":"2025-03-02 06:59","pubTimestamp":1740869966,"startTime":"0","endTime":"0","summary":"ASX:IMR Earnings and Revenue History March 1st 2025. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is forecast to grow 88% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Medical Equipment industry in Australia.The company's share price is broadly unchanged from a week ago.Before we wrap up, we've discovered 3 warning signs for Imricor Medical Systems that you should be aware of.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imricor-medical-systems-reports-full-225926665.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IMR.AU"],"gpt_icon":0},{"id":"2516344307","title":"When Will Imricor Medical Systems, Inc. (ASX:IMR) Breakeven?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516344307","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516344307?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:44","pubTimestamp":1740779079,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Imricor Medical Systems, Inc.'s  business as it appears the company may be on the cusp of a considerable accomplishment. Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging  compatible products for cardiac catheter ablation procedures in the United States. The AU$427m market-cap company posted a loss in its most recent financial year of US$23m and a latest trailing-twelve-month loss of US$20m shrinking the gap between loss and breakeven. The most pressing concern for investors is Imricor Medical Systems' path to profitability – when will it breakeven?Below we will provide a high-level summary of the industry analysts’ expectations for the company.View our latest analysis for Imricor Medical Systems. According to some industry analysts covering Imricor Medical Systems, breakeven is near. They anticipate the company to incur a final loss in 2026, before generating po","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imricor-medical-systems-inc-asx-214439083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7007","MRI.AU","BK7508","IMR.AU","BK7057","BK7503"],"gpt_icon":0},{"id":"2514447278","title":"Corrected-Imricor Medical Systems Inc - Net Loss for Year $29.7 Mln (Corrects Currency to USD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514447278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514447278?lang=en_us&edition=fundamental","pubTime":"2025-02-27 14:17","pubTimestamp":1740637037,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL5N3PI0DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IMR.AU","BK7508","BK7503"],"gpt_icon":0},{"id":"2514843629","title":"BUZZ-Australia's Imricor Medical Systems rises after annual loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2514843629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514843629?lang=en_us&edition=fundamental","pubTime":"2025-02-27 12:15","pubTimestamp":1740629738,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imricor Medical Systems rises after annual loss narrows** Shares of Imricor Medical Systems IMR.AX rise 4.5% to A$1.525** Stock rose as much as 7.2% to A$1.565 earlier in the day, its largest intraday pct gain since February 14** The medical device developer narrows FY24 adjusted net loss to $15.6 million vs $16.7 million last year** Also logs revenue $959,424 for fiscal 2024, up from $615,568 last year** Says revenue growth driven by capital sales and new site activations** More than 258,000 shares change hands vs 30-day avg volume of 236,000 shares** Stock up 13.2% YTD, including current session's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI0AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7508","IMR.AU","BK7503"],"gpt_icon":0},{"id":"2514132498","title":"BRIEF-Imricor Medical Systems Says Net Loss For Year A$29.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132498","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514132498?lang=en_us&edition=fundamental","pubTime":"2025-02-27 09:15","pubTimestamp":1740618958,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Says Net Loss For Year A$29.7 MillionFeb 27 (Reuters) - Imricor Medical Systems Inc IMR.AX:NET LOSS FOR YEAR A$29.7 MILLIONFY ADJUSTED NET LOSS A$15.6 MILLIONFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PH1SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IMR.AU","BK7503","BK7508"],"gpt_icon":0},{"id":"2514605358","title":"Imricor Medical Systems - FY Adjusted Net Loss a$15.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514605358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514605358?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:07","pubTimestamp":1740604059,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1SB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7007","BK7503","IMR.AU"],"gpt_icon":0},{"id":"2512433491","title":"Imricor Medical Systems' Catheter Receives CE Mark Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=2512433491","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512433491?lang=en_us&edition=fundamental","pubTime":"2025-02-19 09:59","pubTimestamp":1739930373,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems (ASX:IMR) said that its second-generation vision-magnetic resonance ablation catheter to be used for the potential treatment of type 1 atrial flutter has received CE mark certi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["A27.SI","BK7094","BK6057","BK7007","CE","BK4109","XAO.AU","Y3D.SI","IMR.AU","BK4585","BK7503","BK7508","MDR.AU","XKO.AU","XJO.AU","BK4588"],"gpt_icon":0},{"id":"2505003419","title":"Imricor Medical Systems' Consumables Revenue Soars in Q4 2024; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505003419","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505003419?lang=en_us&edition=fundamental","pubTime":"2025-01-24 11:04","pubTimestamp":1737687867,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  reported an 840% year-on-year surge to AU$255,000 in its consumables revenue for the fourth quarter of 2024, according to a Thursday filing with the Australian bourse.Total revenue reached AU$280,000, excluding the company's first capital sale in Qatar. The sale will be recognized in future quarters upon installation, per the filing.Cash and cash equivalents at the end of the fourth quarter stood at $15.7 million.The medical device maker's shares rose past 3% in recent Friday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU"],"gpt_icon":0},{"id":"2500151638","title":"5E Advanced Materials grabs first Runners gong for new year","url":"https://stock-news.laohu8.com/highlight/detail?id=2500151638","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500151638?lang=en_us&edition=fundamental","pubTime":"2025-01-03 06:01","pubTimestamp":1735855288,"startTime":"0","endTime":"0","summary":"This week’s Bulls N’ Bears Runner of the Week is… 5E Advanced Materials, up 86 per cent following its booming Nasdaq dual listed price and a focus on becoming a vertically integrated and global boron producer.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-17273723/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-17273723/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/5e-advanced-materials-grabs-first-runners-gong-for-new-year-c-17273723","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/5e-advanced-materials-grabs-first-runners-gong-for-new-year-c-17273723","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["LU0572108347.SGD","BK7508","5EA.AU","LYN.AU","LU1861219969.SGD","MXR.AU","LU1861214812.USD","BK4544","BK4096","BK4093","IE00B66KJ199.SGD","IMR.AU","LU0505663152.USD","ARKG","IE0031619046.USD","BK4109","BK4157","IE00B7SZL793.SGD","BK7007","AEIS","BK4585","IE00B19Z4B17.USD","LU0072463663.USD","BK7095","BK4545","SQM","BK4588","BK7503"],"gpt_icon":0},{"id":"2495129551","title":"Why Brainchip, Imricor, Strike Energy, and Wildcat shares are rising today","url":"https://stock-news.laohu8.com/highlight/detail?id=2495129551","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495129551?lang=en_us&edition=fundamental","pubTime":"2024-12-30 08:50","pubTimestamp":1735519848,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index  is on course to start the week with a decline. At the time of writing, the benchmark index is down 0.45% to 8,225.3 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising: Brainchip Holdings Ltd  The Brainchip share price is up almost 10% to 40 cents. This is despite there being no news out of the semiconductor company. However, this strong gain is a continuation of a recent uptrend in its share price on the back of no news. In fact, at the end of last week, Brainchip was hit with a speeding ticket because of its gains. The Australian stock exchange operator asked: \"Is BRN aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities?\" It simply answered \"No\". It also gave the same response to the follow up question: \"is there any other explanation that BRN may have for the recent trading in its securit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/12/30/why-brainchip-imricor-strike-energy-and-wildcat-shares-are-rising-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["STX.AU","XJO.AU","BK7007","BK7016","BK7506","BK7095","IMR.AU","WC8.AU","BK7503","BK7508","BRN.AU","BK7142"],"gpt_icon":1},{"id":"2495559161","title":"BRIEF-Imricor Medical Systems Received First Purchase Order From Qatar","url":"https://stock-news.laohu8.com/highlight/detail?id=2495559161","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495559161?lang=en_us&edition=fundamental","pubTime":"2024-12-30 08:35","pubTimestamp":1735518911,"startTime":"0","endTime":"0","summary":"Dec 30 (Reuters) - Imricor Medical Systems Inc   :   * RECEIVED ITS FIRST PURCHASE ORDER FOR CAPITAL EQUIPMENT AND CONSUMABLES FROM QATARFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMR.AU","BK7007","BK7503"],"gpt_icon":0},{"id":"2495598375","title":"Imricor Medical Systems Secures First Order for Imaging System in Middle East; Shares Climb 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495598375","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495598375?lang=en_us&edition=fundamental","pubTime":"2024-12-30 08:25","pubTimestamp":1735518326,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  secured the first order for equipment and consumables comprising its real-time cardiac ablation imaging technology in Qatar, according to a Monday filing with the Australian bourse.The sale was made following regulatory approvals for the cardiac imaging system in both Qatar and Saudi Arabia earlier in the year, the filing said.The company's shares surged past 9% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7007","BK7508","BK7503"],"gpt_icon":0},{"id":"2495855554","title":"BUZZ-Australia's Imricor Medical Systems jumps on purchase order","url":"https://stock-news.laohu8.com/highlight/detail?id=2495855554","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495855554?lang=en_us&edition=fundamental","pubTime":"2024-12-30 07:49","pubTimestamp":1735516197,"startTime":"0","endTime":"0","summary":"** Shares of Australia's Imricor Medical Systems    rise as much as 9.4% to A$1.280, their highest level since Dec. 5   ** Stock posts its biggest intraday pct gain since Dec. 23; on track for a second straight session of gain, if current trend holds   ** Medical device maker says it has received first purchase order with distributor East Agency WWL    ** Purchase order to bring MRI compatible ablation tools to cardiac centres in Qatar       ** East Agency WWL is the exclusive distributor of Imricor products in Qatar under a five-year agreement - IMR    ** Stock had more than doubled in value this year, as of last close ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IMR.AU","BK7508","BK7503"],"gpt_icon":0},{"id":"2495537208","title":"Imricor Medical Systems Inc - Received Its First Purchase Order for Capital Equipment and Consumables From Qatar","url":"https://stock-news.laohu8.com/highlight/detail?id=2495537208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495537208?lang=en_us&edition=fundamental","pubTime":"2024-12-30 06:05","pubTimestamp":1735509919,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241229:nFWN3NU00A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMR.AU","BK7503","BK7007"],"gpt_icon":0},{"id":"2493274715","title":"Imricor Medical Systems Submits 3D Mapping System for CE Mark Approval in Europe; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493274715","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493274715?lang=en_us&edition=fundamental","pubTime":"2024-12-23 09:24","pubTimestamp":1734917060,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  submitted the NorthStar 3D mapping system for CE Mark approval in Europe, marking the final stage before commercial rollout across Europe and the Middle East, according to a Monday filing with the Australian bourse.The company anticipates US Food and Drug Administration approval for its consumable ablation tools in the second half of 2025 with NorthStar's expedited approval processes in Europe and the US, the filing said.Meanwhile, the first-in-human ventricular tachycardia ablation guided by real-time magnetic resonance imaging will take place next year, according to the filing.Shares rose nearly 7% in morning trade Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7503","BK4109","BK4585","IMR.AU","BK7007","CE","BK4588"],"gpt_icon":0}],"pageSize":16,"totalPage":2,"pageCount":1,"totalSize":28}]}}